Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,106 | -19,332 | -7,220 | -3,465 | -1,985 |
| Depreciation Amortization | 470 | 1,907 | 1,994 | 995 | 504 |
| Accounts receivable | -6 | -3,363 | -1,770 | -1,358 | 197 |
| Accounts payable and accrued liabilities | 108 | 576 | 107 | -94 | -157 |
| Other Working Capital | 917 | -1,215 | -2,699 | -3,066 | -1,319 |
| Other Operating Activity | -102 | 9,861 | 1,663 | 1,452 | -40 |
| Operating Cash Flow | $-3,719 | $-11,566 | $-7,925 | $-5,536 | $-2,800 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,769 | 1,631 | -5,070 | -4,450 | -6,599 |
| PPE Investments | -480 | -2,407 | -1,836 | -1,197 | -676 |
| Purchase Sale Intangibles | N/A | -511 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -511 | 0 | 0 | 0 |
| Investing Cash Flow | $-26,249 | $-1,287 | $-6,906 | $-5,647 | $-7,275 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -435 | -236 | -177 | -117 | -59 |
| Common Stock Issued | 228 | 834 | 325 | 370 | 127 |
| Financing Cash Flow | $-207 | $598 | $148 | $253 | $68 |
| Beginning Cash Position | 90,462 | 102,717 | 101,917 | 101,917 | 101,917 |
| End Cash Position | 60,287 | 90,462 | 87,234 | 90,987 | 91,910 |
| Net Cash Flow | $-30,175 | $-12,255 | $-14,683 | $-10,930 | $-10,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,719 | -11,566 | -7,925 | -5,536 | -2,800 |
| Capital Expenditure | -480 | -2,407 | -1,836 | -1,197 | -676 |
| Free Cash Flow | -4,199 | -13,973 | -9,761 | -6,733 | -3,476 |